Hot Results
Quick Search
Large-scale studies
- Genome-wide Association Studies of ADHD
- Genome-wide Linkage Studies of ADHD
- Genome-wide CNV Analyses of ADHD
- Meta-analysis Studies of ADHD
Data Summary
Study Report
Reference | Lasky-Su J, 200818821565 |
---|---|
Citation | Lasky-Su J., Neale B. M., Franke B., Anney R. J., Zhou K., Maller J. B., Vasquez A. A., Chen W., Asherson P., Buitelaar J., Banaschewski T., Ebstein R., Gill M., Miranda A., Mulas F., Oades R. D., Roeyers H., Rothenberger A., Sergeant J., Sonuga-Barke E., Steinhausen H. C., Taylor E., Daly M., Laird N., Lange C. and Faraone S. V. (2008) "Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations." Am J Med Genet B Neuropsychiatr Genet, 147B(8): 1345-54. |
Study Design | family-based |
Study Type | GWAS |
Sample Size | 958 trios |
Predominant Ethnicity | Caucasian |
Population | Belgium, Germany, Ireland, the Netherlands, Spain, Switzerland, United Kingdom, Israel |
Gender | 816(86.99%) males |
Age Group | Children/Adolescents : aged 5-17, mean age 10.88 years (SD=2.81) |
Summary | In order to identify novel ADHD susceptibility genes, 600,000 SNPs were genotyped in 958 ADHD proband-parent trios. After applying data cleaning procedures 429,981 autosomal SNPs in 909 family trios were examined. They generated six quantitative phenotypes from 18 ADHD symptoms to be used in genome-wide association analyses.With the PBAT screening algorithm, they identified 2 SNPs, rs6565113 and rs552655 that met the criteria for significance within a specified phenotype. These SNPs are located in intronic regions of genes CDH13 and GFOD1, respectively. They also evaluated the association of SNPs from a list of 37 ADHD candidate genes that was specified a priori. These findings, along with association p-values with a magnitude less than 10-5 ,are discussed in this manuscript. Seventeen of these candidate genes had association p-values lower then 0.01: SLC6A1, SLC9A9,HES1, ADRB2,HTR1E, DDC, ADRA1A, DBH, DRD2, BDNF, TPH2, HTR2A, SLC6A2, PER1, CHRNA4, SNAP25, and COMT. Among the candidate genes, SLC9A9 had the strongest overall associations with 58 association test p-values lower than 0.01 and multiple association p-values at a magnitude of 10-5 in this gene. In sum, these findings identify novel genetic associations at viable ADHD candidate genes and provide confirmatory evidence for associations at previous candidate genes. Replication of these results is necessary in order to confirmthe proposed genetic variants for ADHD. |
---|---|
Total Sample | A total of 958 affected proband-parent trios were initially selected for the GWAS scan. A total of 2,803 individuals, 1,865 founders and 938 non-founders were included after the cleaning process. Of these individuals, 29 offspring did not have clinical data and/or parental genotypes resulting in 909 individuals used in the analysis. |
Sample Collection | Families were collected by the International Multicenter ADHD Genetics (IMAGE) project. Family members were Caucasians of European origin from seven countries around Europe including Belgium, Germany, Ireland, the Netherlands, Spain, Switzerland, and The United Kingdom, as well as Israel. |
Diagnosis Description | Of 958 affected proband-parent trios, 936 probands were initially ascertained as having DSM-IV combined type ADHD. Twenty-two probands who did not meet combined subtype ADHD diagnosis were included because they either met the criteria for the inattentive or hyperactive subtypes, or theymissed the DSM-IV combined type diagnosis by a single item. Exclusion criteria were autism, epilepsy, IQ<70, brain disorders and any genetic or medical disorder associated with externalizing behaviors that might mimic ADHD. For detailed information about clinical measures, please refer to the origianl paper. |
Technique | Details of the genotyping and data cleaning process were reported elsewhere (Neale et al., 2008). Briefly, genotyping was performed by Perlegen Sciences using the Perlegen platform. The Perlegen Array has 600,000 tagging SNPs designed to be in high linkage disequilibrium with untyped SNPs for the three HapMap populations. Genotype data cleaning and quality control procedures were done by The National Center for Biotechnology Information (NCBI) using the GAIN QA/QC Software Package (version 0.7.4) developed by Goncalo Abecasis and Shyam Gopalakrishnan at the University of Michigan. For more information about quality control metrics, please refer to the original paper. |
Analysis Method | They analyzed their data using the FBAT¨CPC methodology in the context of the PBAT screening algorithm. They also performed a cluster analysis in PLINK through a linkage clustering algorithm that is based on pairwise identity-by-state distance, to identify a predominant homogeneous cluster in their sample. Information from this cluster was used to rank-order the SNPs using the PBAT screening algorithm. Using the PBAT screening algorithm they only formally test the top 10 ranked SNPs, and therefore genome-wide significance can be established using a much more liberal threshold than the 10-8 that has been suggested for formal testing of all SNPs. In all analyses, they considered additive, dominant, and recessive genetic models. |
Result Description | Two SNPs achieved significance within the specified GWAS analysis. If adjust for selected SNPs from all 18 GWAS analyses, these SNPs do not achieve significance. Among all 18 GWAS analyses, there were 58 association tests with 46 unique SNPs that had a P-value<10-5. There were numerous associations at the candidate gene SNPs with a P-value<0.01. |
SNP | Allele Change | Risk Allele | Statistical Values | Author Comments | Result of Statistical Analysis |
---|---|---|---|---|---|
rs1018040 | P-value=4.64E-06 under Additive model for FBAT-PC all symptoms; P-value=2.97E-06 under Dominant model for FBAT-PC all symptoms; P-value=8.20E-06 under Additive model for FBAT-PC HI symptoms |
association finding with P-value |
Trend | ||
rs10767942 | P-value=7.90E-06 under Dominant model for Total ADHD symptom count |
association finding with P-value |
Trend | ||
rs10895959 | P-value=3.00E-06 under Recessive model for FBAT-PC IA symptoms |
association finding with P-value |
Trend | ||
rs10227331 | P-value=3.79E-06 under Recessive model for IA symptom count |
association finding with P-value |
Trend | ||
rs10421632 | P-value=9.68E-06 under Additive model for HI symptom count |
association finding with P-value |
Trend | ||
rs17281813 | P-value=3.46E-06 under Recessive model for FBAT-PC IA symptoms |
association finding with P-value |
Trend | ||
rs17079773 | P-value=4.71E-06 under Additive model for FBAT-PC IA symptoms; P-value=6.60E-06 under Dominant model for FBAT-PC IA symptoms |
association finding with P-value |
Trend | ||
rs17641078 | P-value=4.73E-06 under Additive model for FBAT-PC HI symptoms; P-value=8.44E-06 under Dominant model for FBAT-PC HI symptoms |
association finding with P-value |
Trend | ||
rs17367118 | P-value=8.69E-06 under Additive model for Total ADHD symptom count |
association finding with P-value |
Trend | ||
rs1350666 | P-value=8.30E-06 under Additive model for FBAT-PC all symptoms |
association finding with P-value |
Trend | ||
rs13353224 | P-value=8.54E-06 under Additive model for HI symptom count |
association finding with P-value |
Trend | ||
rs1514928 | P-value=3.05E-06 under Additive model for FBAT-PC all symptoms |
association finding with P-value |
Trend | ||
rs1471225 | P-value=8.09E-06 under Additive model for IA symptom count |
association finding with P-value |
Trend | ||
rs12679254 | P-value=2.08E-06 under Recessive model for FBAT-PC IA symptoms |
association finding with P-value |
Trend | ||
rs1202199 | P-value=8.52E-06 under Dominant model for HI symptom count |
association finding with P-value |
Trend | ||
rs13330107 | P-value=8.50E-06 under Recessive model for FBAT-PC IA symptoms |
association finding with P-value |
Trend | ||
rs130575 | P-value=4.67E-06 under Additive model for FBAT-PC all symptoms; P-value=6.20E-06 under Dominant model for FBAT-PC all symptoms |
association finding with P-value |
Trend | ||
rs11719664 | P-value=2.48E-06 under Additive model for Total ADHD symptom count |
association finding with P-value |
Trend | ||
rs11590090 | P-value=2.51E-06 under Recessive model for HI symptom count |
association finding with P-value |
Trend | ||
rs11790994 | P-value=2.47E-07 under Additive model for FBAT-PC IA symptoms |
association finding with P-value |
Trend | ||
rs11786458 | P-value=8.76E-06 under Additive model for FBAT-PC IA symptoms |
association finding with P-value |
Trend | ||
rs478597 | P-value=8.08E-06 under Additive model for FBAT-PC IA symptoms |
association finding with P-value |
Trend | ||
rs522958 | P-value=1.03E-06 under Recessive model for FBAT-PC all symptoms; P-value=7.59E-07 under Recessive model for FBAT-PC HI symptoms |
association finding with P-value |
Trend | ||
rs552655 | PBAT P-value=0.004, power ranking=2 within inattentive symptoms phenotype in dominant model | achieved significance within a phenotype using the PBAT scre...... achieved significance within a phenotype using the PBAT screening algorithm with various quantitative phenotypes More... | Significant | ||
rs6565113 | PBAT P-value=0.005, power ranking=1 within all symptoms phenotype in additive model | achieved significance within a phenotype using the PBAT scre...... achieved significance within a phenotype using the PBAT screening algorithm with various quantitative phenotypes More... | Significant | ||
rs4128767 | P-value=1.28E-06 under Dominant model for IA symptom count |
association finding with P-value |
Trend | ||
rs41441749 | P-value=1.49E-06 under Dominant model for FBAT-PC HI symptoms |
association finding with P-value |
Trend | ||
rs4147141 | P-value=7.90E-06 under Additive model for FBAT-PC IA symptoms;P-value=6.07E-06 under Additive model for Total ADHD symptom count |
association finding with P-value |
Trend | ||
rs4650135 | P-value=5.45E-06 under Additive model for FBAT-PC IA symptoms; P-value=6.07E-06 under Dominant model for FBAT-PC IA symptoms |
association finding with P-value |
Trend | ||
rs260461 | P-value=8.38E-06 under Dominant model for FBAT-PC all symptoms |
association finding with P-value |
Trend | ||
rs272000 | P-value=9.10E-06 under Recessive model for Total ADHD symptom count |
association finding with P-value |
Trend | ||
rs2769967 | P-value=3.63E-06 under Recessive model for IA symptom count |
association finding with P-value |
Trend | ||
rs363512 | P-value=3.89E-06 under Dominant model for FBAT-PC HI symptoms |
association finding with P-value |
Trend | ||
rs17651978 | P-value=6.05E-06 under Recessive model for Total ADHD symptom count |
association finding with P-value |
Trend | ||
rs1918172 | P-value=5.18E-06 under Additive model for Total ADHD symptom count |
association finding with P-value |
Trend | ||
rs2014572 | P-value=7.32E-06 under Additive model for HI symptom count |
association finding with P-value |
Trend | ||
rs2290416 | P-value=8.51E-06 under Additive model for Total ADHD symptom count |
association finding with P-value |
Trend | ||
rs930421 | P-value=5.64E-06 under Recessive model for FBAT-PC all symptoms |
association finding with P-value |
Trend | ||
rs8047014 | P-value=3.52E-06 under Additive model for FBAT-PC all symptoms |
association finding with P-value |
Trend | ||
rs8041675 | P-value=3.98E-06 under Additive model for HI symptom count |
association finding with P-value |
Trend | ||
rs7992643 | P-value=5.45E-06 under Dominant model for Total ADHD symptom count |
association finding with P-value |
Trend | ||
rs7816032 | P-value=2.25E-06 under Recessive model for HI symptom count |
association finding with P-value |
Trend | ||
rs7577925 | P-value=2.55E-06 under Dominant model for FBAT-PC all symptoms |
association finding with P-value |
Trend | ||
rs7495052 | P-value=2.83E-06 under Recessive model for FBAT-PC IA symptoms |
association finding with P-value |
Trend | ||
rs7172689 | P-value=3.86E-06 under Additive model for IA symptom count; P-value=1.50E-06 under Dominant model for IA symptom count |
association finding with P-value |
Trend | ||
rs708188 | P-value=7.21E-06 under Recessive model for FBAT-PC all symptoms; P-value=2.17E-06 under Recessive model for FBAT-PC HI symptoms |
association finding with P-value |
Trend | ||
rs6808138 | P-value=5.38E-06 under Additive model for FBAT-PC HI symptoms; P-value=8.21E-06 under Dominant model for FBAT-PC HI symptoms |
association finding with P-value |
Trend | ||
rs6791644 | P-value=8.32E-06 under Recessive model for Total ADHD symptom count |
association finding with P-value |
Trend | ||
rs6719977 | P-value=1.67E-06 under Additive model for FBAT-PC HI symptoms |
association finding with P-value |
Trend |
Gene | Statistical Values/Author Comments | Result of Statistical Analysis |
---|---|---|
SLCO3A1 | 1 flanking SNPs of this gene with P-value<1E-5. 1 flanking SNPs of this gene with P-value<1E-5. | Trend |
EREG | 1 flanking SNPs of this gene with P-value<1E-5. 1 flanking SNPs of this gene with P-value<1E-5. | Trend |
NCKAP5 | 1 flanking SNPs of this gene with P-value<1E-5. 1 flanking SNPs of this gene with P-value<1E-5. | Trend |
CLYBL | 1 flanking SNPs of this gene with P-value<1E-5. 1 flanking SNPs of this gene with P-value<1E-5. | Trend |
NAPRT1 | 1 flanking SNPs of this gene with P-value<1E-5. 1 flanking SNPs of this gene with P-value<1E-5. | Trend |
ZNF423 | 1 flanking SNPs of this gene with P-value<1E-5. 1 flanking SNPs of this gene with P-value<1E-5. | Trend |
OXER1 | 2 flanking SNPs of this gene with P-value<1E-5. 2 flanking SNPs of this gene with P-value<1E-5. | Trend |
FHIT | 1 flanking SNPs of this gene with P-value<1E-5. 1 flanking SNPs of this gene with P-value<1E-5. | Trend |
IL16 | 2 flanking SNPs of this gene with P-value<1E-5. 2 flanking SNPs of this gene with P-value<1E-5. | Trend |
CDH13 | rs6565113 in in this gene was significant within a phenotype...... rs6565113 in in this gene was significant within a phenotype. More... | Significant |
FOXP1 | 1 flanking SNPs of this gene with P-value<1E-5. 1 flanking SNPs of this gene with P-value<1E-5. | Trend |
HAS3 | 1 flanking SNPs of this gene with P-value<1E-5. 1 flanking SNPs of this gene with P-value<1E-5. | Trend |
ZNF805 | 2 flanking SNPs of this gene with P-value<1E-5. 2 flanking SNPs of this gene with P-value<1E-5. | Trend |
ZNF544 | 1 flanking SNPs of this gene with P-value<1E-5. 1 flanking SNPs of this gene with P-value<1E-5. | Trend |
MEIS2 | 1 flanking SNPs of this gene with P-value<1E-5. 1 flanking SNPs of this gene with P-value<1E-5. | Trend |
GFOD1 | rs552655 in in this gene was significant within a phenotype. rs552655 in in this gene was significant within a phenotype. | Significant |
LPL | 1 flanking SNPs of this gene with P-value<1E-5. 1 flanking SNPs of this gene with P-value<1E-5. | Trend |
GRIK1 | 1 flanking SNPs of this gene with P-value<1E-5. 1 flanking SNPs of this gene with P-value<1E-5. | Trend |
DMRT2 | 1 flanking SNPs of this gene with P-value<1E-5. 1 flanking SNPs of this gene with P-value<1E-5. | Trend |
Copyright: Bioinformatics Lab, Institute of Psychology, Chinese Academy of Sciences Feedback
Last update: Feb 26, 2014